HIF1A and hepatocellular carcinoma: It was reported that sorafenib in combination with RFA could improve the treatment of HCC due to sorafenib suppresses cell proliferation and induces apoptosis in hepatoma cells by the HIF-1/VEGFA pathway (Gong et al., 2017).